Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

OMS906, a Novel Alternative Pathway MASP-3 Inhibitor, Normalizes Hemoglobin Levels and Increases Clone Size in Treatment-Naïve PNH Patients

Oksana Karnabeda, Valentyn Moskalenko, Zoreslava Lysak, Narinder Nangia, Charlotte A. Osborne, J. Steve Whitaker, Eleni Gavriilaki, Jens Panse

Blood (2023) 142 (Supplement 1): 573.

https://doi.org/10.1182/blood-2023-177921

Published: 2023

Journal Articles

Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients

Blood (2023) 142 (Supplement 1): 6905.

https://doi.org/10.1182/blood-2023-179506

Published: 2023

Journal Articles

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Blood (2023) 142 (Supplement 1): 7016.

https://doi.org/10.1182/blood-2023-177866

Published: 2023

Journal Articles

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host-Disease

Eleni Gavriilaki, Eleni Papchianou, Ioannis Batsis, Alkistis Kyra Panteliadou, Andriana Lazaridou, Despina Mallouri, Varnavas Constantinou, Georgios Karavalakis, Apostolia Papalexandri, Panayotis Kaloyannidis, Anna Vardi, Christos Smias, Achilles Anagnostopoulos, Ioanna Sakellari

Blood (2023) 142 (Supplement 1): 7006.

https://doi.org/10.1182/blood-2023-173575

Published: 2023

Journal Articles

Complement Activation Is Increased in Antiphospholipid Syndrome-Related Ischemic Stroke with Higher Risk Features

Ibrahim Tohidi-Esfahani, Yiran Xing, Veronica Venturelli, Eleni Gavriilaki, Xi Kang, David Isenberg, Hannah Cohen, Maria Efthymiou

Blood (2023) 142 (Supplement 1): 3943.

https://doi.org/10.1182/blood-2023-182287

Published: 2023

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Leves Are Significantly Associated with Edothelial Injury Indices in Adult Allogenic Hematopoietic Cell Transplantation Recipients

Eleni Gavriilaki, Zoi Bousiou, Ioannis Batsis, Anna Vardi, Despina Mallouri, Evdoxia Koravou, Georgia Konstantinidou, Nikolaos Spyridis, Georgios Karavalakis, Vasileios Patriarcheas, Marianna Masmanidou, Tasoula Touloumenidou, Apostolia Papalexandri, Christos Poziopoulos, Evangelia Yannaki, Ioanna Sakellari, Marianna Politou, Ioannis Papassotiriou

Blood (2023) 142 (Supplement 1): 3573.

https://doi.org/10.1182/blood-2023-178241

Published: 2023

Journal Articles

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Cellular Therapies: A Real-World Analysis

Eleni Gavriilaki, Panagiotis Dolgyras, Sotiria Dimou-Mpesikli, Aikaterini Poulopoulou, Christos Demosthenous, Evangelia Zachrou, Panagiotis Siasios, Despina Mallouri, Anna Vardi, Zoi Bousiou, Alkistis Panteliadou, Marianna Masmanidou, Chrysavgi Lalayanni, Evangelia Yannaki, Damianos Sotiropoulos, Achilles Anagnostopoulos, Timoleon Achilleas Vyzantiadis, Ioanna Sakellari

Blood (2022) 140 (Supplement 1): 4790–4791.

https://doi.org/10.1182/blood-2022-156570

Published: 2022

Journal Articles

Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease

Christos Varelas, Efthymia Vlachaki, Filippos Klonizakis, Despoina Pantelidou, Fani Minti, Michael D. Diamantidis, Nikolaos Sampanis, Ioanna Giatagantzidou, Despoina Papadopoulou, Evdoxia Koravou, Ioanna Christodoulou, Evaggelia Zarkada, Tasoula Touloumenidou, Apostolia Papalexandri, Ioanna Sakellari, George Vassilopoulos, Robert Brodsky, Eleni Gavriilaki

Blood (2022) 140 (Supplement 1): 2504–2505.

https://doi.org/10.1182/blood-2022-164554

Published: 2022

Journal Articles

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Blood (2022) 140 (Supplement 1): 8503–8504.

https://doi.org/10.1182/blood-2022-158549

Published: 2022

Journal Articles

Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond

Eleni Gavriilaki, Régis Peffault de Latour, Antonio Maria Risitano

Blood (2022) 139 (25): 3571–3582.

https://doi.org/10.1182/blood.2021012860

Published: 2022

Journal Articles

Comparative Study of Treosulfan Plus Fludarabine (FT14) with Busulfan Plus Fludarabine (FB4) for Acute Myeloid Leukemia in First or Second Complete Remission: An Analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Blood (2021) 138 (Supplement 1): 1787.

https://doi.org/10.1182/blood-2021-146303

Published: 2021

Journal Articles

Chimeric Antigen Receptor T Cells for Refractory/Relapsed Diffuse Large B Cell Lymphoma and Acute Lymphoblastic Leukemia: The Hellenic Real-World Experience in Adult Patients

Ioannis Baltadakis, Despina Mallouri, Ioannis Tsonis, Eleni Gavriilaki, Maria Bouzani, Ioannis Batsis, Ifigeneia Tzannou, Tatiana Tzenou, Christos Varelas, Thomas Chatzikonstantinou, Damianos Sotiropoulos, Stavros Gigantes, Ioanna Sakellari, Dimitrios Karakasis, Achilles Anagnostopoulos

Blood (2021) 138 (Supplement 1): 4840.

https://doi.org/10.1182/blood-2021-153094

Published: 2021

Journal Articles

Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes

Blood (2021) 138 (Supplement 1): 3154.

https://doi.org/10.1182/blood-2021-149382

Published: 2021

Journal Articles

Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients

Eleni Gavriilaki, Anastasia Papadopoulou, Tasoula Touloumenidou, Fani Stavridou, Evdoxia Koravou, Maria Giannaki, Apostolia Papalexandri, Georgios Karavalakis, Ioannis Batsis, Andreas Kourelis, Fani Chatzopoulou, Dimitrios Chatzidimitriou, Damianos Sotiropoulos, Evangelia Yannaki, Ioanna Sakellari, Achilles Anagnostopoulos

Blood (2021) 138 (Supplement 1): 2896.

https://doi.org/10.1182/blood-2021-149399

Published: 2021

Journal Articles

Allogeneic Hematopoietic Cell Transplantation with Myeloablative Conditioning Regimen of Reduced Toxicity Is Associated with Favorable Survival in Patients with Secondary Acute Myeloid Leukemia

Eleni Gavriilaki, MD, Chrysavgi Lalayanni, Ioanna Sakellari, MDPhD, Christos Varelas, MD MSc, Despina Mallouri, Ioannis Batsis, Anna Vardi, MD PhD, Sofia Tagara, Marianna Masmanidou, Maria Papathanasiou, Lila Papalexandri, MD, Chrysanthi Vadikoliou, Anastasia Athanasiadou, MDPhD, Achilles Anagnostopoulos

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-134313

Published: 2020

Journal Articles

Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139304

Published: 2020

Journal Articles

Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

Apostolia Papalexandri, MD, Eleni Gavriilaki, MD, Anna Vardi, MD PhD, Eirini Baldoumi, Christos Demosthenous, MD, Natasa Konstantinou, MD, Tasoula Touloumenidou, Panagiota Zerva, Fotini Kika, Angeliki Paleta, Michalis Iskas, Ioannis Batsis, Despina Mallouri, Evangelia Yannaki, MD, Ioanna Sakellari, MDPhD, Achilles Anagnostopoulos

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-141596

Published: 2020

Journal Articles

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Shruti Chaturvedi, Evan M. Braunstein, Xuan Yuan, Jia Yu, Alice Alexander, Hang Chen, Eleni Gavriilaki, Ravi Alluri, Michael B. Streiff, Michelle Petri, Mark A. Crowther, Keith R. McCrae, Robert A. Brodsky

Blood (2020) 135 (4): 239–251.

https://doi.org/10.1182/blood.2019003863

Published: 2020

Includes: Supplemental data

Journal Articles

Easix Is Strongly Associated with Complement Activation and Overall Survival in Adult Allogeneic Hematopoietic Cell Transplantation Recipients

Eleni Gavriilaki, MD, Ioanna Sakellari, Thomas Chatziconstantinou, Despina Mallouri, Ioannis Batsis, Anna Vardi, MD PhD, Zoi Bousiou, MD MSc, Evdoxia Koravou, Marianna Masmanidou, Tasoula Touloumenidou, Lila Papalexandri, MD, Anastasia Athanasiadou, MD, Evangelia Yannaki, MD, Achilles Anagnostopoulos

Blood (2019) 134 (Supplement_1): 4520.

https://doi.org/10.1182/blood-2019-125332

Published: 2019

Journal Articles

Risk Factors and Outcomes of Klebsiella Pneumoniae Infection before and after Allogeneic Hematopoietic Cell Transplantation

Eleni Gavriilaki, MD, Ioanna Sakellari, Thomas Chatziconstantinou, Despina Mallouri, Ioannis Batsis, Eleni Katsifa, Stergios Papadimitriou, Alkistis Panteliadou, MD, Eirini Baldoumi, Christos Demosthenous, MD, Zoi Bousiou, MD MSc, Varnavas Constantinou, Damianos Sotiropoulos, MD, Achilles Anagnostopoulos

Blood (2019) 134 (Supplement_1): 4502.

https://doi.org/10.1182/blood-2019-125320

Published: 2019

NARROW

OMS906, a Novel Alternative Pathway MASP-3 Inhibitor, Normalizes Hemoglobin Levels and Increases Clone Size in Treatment-Naïve PNH Patients

Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host-Disease

Complement Activation Is Increased in Antiphospholipid Syndrome-Related Ischemic Stroke with Higher Risk Features

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Leves Are Significantly Associated with Edothelial Injury Indices in Adult Allogenic Hematopoietic Cell Transplantation Recipients

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Cellular Therapies: A Real-World Analysis

Prospective Study of Complement Activation with Functional and Genetic Assays in Sickle Cell Disease

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment

Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond

Comparative Study of Treosulfan Plus Fludarabine (FT14) with Busulfan Plus Fludarabine (FB4) for Acute Myeloid Leukemia in First or Second Complete Remission: An Analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Chimeric Antigen Receptor T Cells for Refractory/Relapsed Diffuse Large B Cell Lymphoma and Acute Lymphoblastic Leukemia: The Hellenic Real-World Experience in Adult Patients

Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes

Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients

Allogeneic Hematopoietic Cell Transplantation with Myeloablative Conditioning Regimen of Reduced Toxicity Is Associated with Favorable Survival in Patients with Secondary Acute Myeloid Leukemia

Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients

Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

Easix Is Strongly Associated with Complement Activation and Overall Survival in Adult Allogeneic Hematopoietic Cell Transplantation Recipients

Risk Factors and Outcomes of Klebsiella Pneumoniae Infection before and after Allogeneic Hematopoietic Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only